CELG - Celgene Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue15,281,00013,003,00011,229,0009,256,000
Cost of Revenue1,219,0001,294,0001,365,0001,949,000
Gross Profit14,062,00011,709,0009,864,0007,307,000
Operating Expenses
Research Development5,101,0003,274,0003,543,0002,089,000
Selling General and Administrative3,154,0002,626,0002,459,0002,300,000
Non Recurring----
Others----
Total Operating Expenses9,792,0007,523,0007,826,0006,617,000
Operating Income or Loss5,489,0005,480,0003,403,0002,639,000
Income from Continuing Operations
Total Other Income/Expenses Net-657,000-1,166,000-1,031,000-616,000
Earnings Before Interest and Taxes5,489,0005,480,0003,403,0002,639,000
Interest Expense-741,000-522,000-500,000-311,000
Income Before Tax4,832,0004,314,0002,372,0002,023,000
Income Tax Expense786,0001,374,000373,000421,000
Minority Interest----
Net Income From Continuing Ops4,046,0002,940,0001,999,0001,602,000
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income4,046,0002,940,0001,999,0001,602,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares4,046,0002,940,0001,999,0001,602,000